Editorial: Cardiovascular remodeling

Yan Yang; Yi Zhang; Gui-Rong Li; Ming Lei

doi:10.3389/fphar.2023.1252598

Editorial: Cardiovascular remodeling

Front Pharmacol. 2023 Jul 24:14:1252598. doi: 10.3389/fphar.2023.1252598. eCollection 2023.

Authors

Yan Yang¹, Yi Zhang², Gui-Rong Li³, Ming Lei⁴

Affiliations

¹ Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China.
² Department of Physiology, Hebei Medical University, Shijiazhuang, China.
³ Nanjing Amazigh Pharma Ltd., Nanjing, China.
⁴ Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

Abstract

Keywords: cardiovascular diseases (CVDs); cardiovascular remodeling; drug therapy; dysfunction; genetic studies.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundations of China (grant numbers 31972909, 82070502, and 32171099) and the Sichuan Science and Technology Program (grant numbers 2022YFS0607, 23NSFSC1456, and 2021YJ0213).